IT1401351B1 - PHARMACEUTICAL COMPOSITION BASED ON ONE OR MORE HYALURONIC ACID FRACTIONS OR ITS SALTS ASSOCIATED WITH AN INHIBITOR OF IALURONIDASI AND ITS USES IN MEDICAL FIELD - Google Patents

PHARMACEUTICAL COMPOSITION BASED ON ONE OR MORE HYALURONIC ACID FRACTIONS OR ITS SALTS ASSOCIATED WITH AN INHIBITOR OF IALURONIDASI AND ITS USES IN MEDICAL FIELD

Info

Publication number
IT1401351B1
IT1401351B1 ITRM2010A000419A ITRM20100419A IT1401351B1 IT 1401351 B1 IT1401351 B1 IT 1401351B1 IT RM2010A000419 A ITRM2010A000419 A IT RM2010A000419A IT RM20100419 A ITRM20100419 A IT RM20100419A IT 1401351 B1 IT1401351 B1 IT 1401351B1
Authority
IT
Italy
Prior art keywords
ialuronidasi
inhibitor
pharmaceutical composition
hyaluronic acid
medical field
Prior art date
Application number
ITRM2010A000419A
Other languages
Italian (it)
Inventor
Sandro Soriano
Original Assignee
Galsor S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galsor S R L filed Critical Galsor S R L
Priority to ITRM2010A000419A priority Critical patent/IT1401351B1/en
Publication of ITRM20100419A1 publication Critical patent/ITRM20100419A1/en
Application granted granted Critical
Publication of IT1401351B1 publication Critical patent/IT1401351B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ITRM2010A000419A 2010-07-28 2010-07-28 PHARMACEUTICAL COMPOSITION BASED ON ONE OR MORE HYALURONIC ACID FRACTIONS OR ITS SALTS ASSOCIATED WITH AN INHIBITOR OF IALURONIDASI AND ITS USES IN MEDICAL FIELD IT1401351B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ITRM2010A000419A IT1401351B1 (en) 2010-07-28 2010-07-28 PHARMACEUTICAL COMPOSITION BASED ON ONE OR MORE HYALURONIC ACID FRACTIONS OR ITS SALTS ASSOCIATED WITH AN INHIBITOR OF IALURONIDASI AND ITS USES IN MEDICAL FIELD

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM2010A000419A IT1401351B1 (en) 2010-07-28 2010-07-28 PHARMACEUTICAL COMPOSITION BASED ON ONE OR MORE HYALURONIC ACID FRACTIONS OR ITS SALTS ASSOCIATED WITH AN INHIBITOR OF IALURONIDASI AND ITS USES IN MEDICAL FIELD

Publications (2)

Publication Number Publication Date
ITRM20100419A1 ITRM20100419A1 (en) 2012-01-29
IT1401351B1 true IT1401351B1 (en) 2013-07-18

Family

ID=43569381

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM2010A000419A IT1401351B1 (en) 2010-07-28 2010-07-28 PHARMACEUTICAL COMPOSITION BASED ON ONE OR MORE HYALURONIC ACID FRACTIONS OR ITS SALTS ASSOCIATED WITH AN INHIBITOR OF IALURONIDASI AND ITS USES IN MEDICAL FIELD

Country Status (1)

Country Link
IT (1) IT1401351B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202100024544A1 (en) * 2021-09-24 2023-03-24 Federico Montanari Association of molecular oxygen and hyaluronic acid or its salts for use in the treatment of candidiasis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2154103C (en) * 1995-07-18 1998-02-24 Samuel Simon Asculai Treatment of mucous membrane disease, trauma or condition and for the relief of pain
ITMI20051777A1 (en) * 2005-09-23 2007-03-24 Pharmaproducts Uk Ltd COLOSSUS-BASED COMPOSITIONS FOR VAGINAL DRYING TREATMENT

Also Published As

Publication number Publication date
ITRM20100419A1 (en) 2012-01-29

Similar Documents

Publication Publication Date Title
SMT201600021B (en) NEW CHINOLINA COMPOUNDS REPLACED AS INHIBITORS OF S-NITROSOGLUTATION AND REDUCTASE
BR112013013167A2 (en) bromodomain inhibitors and their uses
SMT201600272B (en) DIIDROPYRIDINONS AND ARYL PIPERIDINONS AS INHIBITORS OF MGAT2
IL224389A (en) Arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use
SMT201500122B (en) Triazolopyridine compound and its action as an inhibitor of prolylhydroxylase and inducer of erythropoientine production
DK3329919T3 (en) ACC INHIBITORS AND APPLICATIONS THEREOF
HK1200095A1 (en) Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereof
SMT201500300B (en) Methods of use of ALK inhibitors
HK1203853A1 (en) Inhibitors of arginase and their therapeutic applications
BR112013010834A2 (en) modified factor ix polypeptides and uses thereof
BR112013019633A2 (en) connector containing a dielectric seal and its method of use
CO7020907A2 (en) Quinurenine-3-monooxygenase inhibitors, pharmaceutical compositions and methods of use thereof
BR112014001991A2 (en) certain quinurenine-3-monooxygenase inhibitors, pharmaceutical compositions and methods of use thereof
DK2531181T3 (en) FORMULATIONS OF RASAGILIN WITH EXTENDED DELIVERY AND USES THEREOF
IT1401498B1 (en) HYDROGEL BASED ON HYALURONIC ACID AND ITS USE IN ORTHOPEDICS
BR112014006291A2 (en) composition and use of composition
SMT201400127B (en) Use of amisulpride to treat chemotherapy-induced nausea and vomiting
BR112013010331A2 (en) creped adhesive compositions and methods of use of such compositions
DK2427417T3 (en) Salts of 3-pentylphenylacetic acid and pharmaceutical applications thereof
ITMI20121265A1 (en) PROCEDURE FOR DETERMINING THE SIZE AND POSITION OF OBJECTS
DK2556055T3 (en) SHIP INHIBITORS AND APPLICATIONS THEREOF
BR112013012362A2 (en) apoptosis inhibitors and their use
IT1399793B1 (en) PROCEDURE FOR THE PREPARATION OF A BIOMASS INCLUDING PLANTARICINA AND ITS USES IN MEDICAL FIELD.
DK2578590T3 (en) ANTI-INFLAMMATORY RELATIONSHIP WITH INHIBITORIAL ACTIVITY AGAINST MULTIPLE TYROSINKINASAS AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
BR112013030644A2 (en) phospholipids containing nitrocarboxylic acid (s) of general structure (i) and their use, medical device and biopassivative compositions